2020
Does Routinely Provided Directly Observed Treatment Improve Adherence to Bedaquiline in Patients with Drug-Resistant TB HIV in South Africa (Praxis Study)?
Wolf A, Braunlin H, Amico K, Zelnick J, Boodhram R, Orrell C, Daftary A, Friedland G, Padayatchi N, O'Donnell M. Does Routinely Provided Directly Observed Treatment Improve Adherence to Bedaquiline in Patients with Drug-Resistant TB HIV in South Africa (Praxis Study)? 2020, a2690-a2690. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2690.Peer-Reviewed Original Research
2017
Resistência às drogas antituberculose na fronteira do Brasil com Paraguai e Bolívia
Marques M, Cunha E, do Socorro Nantua Evangelista M, Basta P, Marques A, Croda J, de Andrade S. Resistência às drogas antituberculose na fronteira do Brasil com Paraguai e Bolívia. BULL PAN AM HEALTH ORGAN 2017, 41: 1. PMID: 28444009, PMCID: PMC6645181, DOI: 10.26633/rpsp.2017.9.Peer-Reviewed Original ResearchConceptsObserved treatmentDrug resistanceAssociated risk factorsPulmonary tuberculosis casesHistory of alcoholismCases of PTBCombination of drugsPatterns of resistanceRespiratory symptomsPTB casesTuberculosis casesDevelopment of resistanceRisk factorsEpidemiological studiesSingle drugHealth actionsSusceptibility testingMultidrug resistanceDiabetesSusceptibility testsAlcoholismPatientsDrugsTreatmentPresence/absence
2007
Managing multiple and extensively drug-resistant tuberculosis and HIV
Padayatchi N, Friedland G. Managing multiple and extensively drug-resistant tuberculosis and HIV. Expert Opinion On Pharmacotherapy 2007, 8: 1035-1037. PMID: 17516869, DOI: 10.1517/14656566.8.8.1035.Peer-Reviewed Original Research
2003
Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru.
Mukherjee J, Joseph J, Rich M, Shin S, Furin J, Seung K, Sloutsky A, Socci A, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru F, Farmer P, Del Castillo H. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. The International Journal Of Tuberculosis And Lung Disease 2003, 7: 637-44. PMID: 12870684.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisPediatric MDR-TBMonths of therapySecond-line anti-tuberculosis drugsIntermediate outcomesFavorable clinical evolutionShort-course strategyAnti-tuberculosis drugsDOTS-PlusRespiratory insufficiencyRadiographic evidenceClinical evolutionObserved treatmentCase definitionChronic illnessClinical failureCommon causeEarly diagnosisTherapySuch childrenChildrenPatientsTreatmentTuberculosisProgrammatic considerations
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply